Globus Medical (GMED) - Total Liabilities
Based on the latest financial reports, Globus Medical (GMED) has total liabilities worth $707.24 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Globus Medical - Total Liabilities Trend (2010–2025)
This chart illustrates how Globus Medical's total liabilities have evolved over time, based on quarterly financial data. See working capital to net assets of Globus Medical to evaluate short-term liquidity relative to the company's equity base.
Globus Medical Competitors by Total Liabilities
The table below lists competitors of Globus Medical ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Gartner Inc
NYSE:IT
|
USA | $7.77 Billion |
|
L E Lundbergföretagen AB (publ)
ST:LUND-B
|
Sweden | Skr60.77 Billion |
|
YTL Power International Bhd
KLSE:6742
|
Malaysia | RM50.91 Billion |
|
ALD SA
PA:AYV
|
France | €59.81 Billion |
|
Toro Co
NYSE:TTC
|
USA | $2.28 Billion |
|
Embraer S.A
F:EMY
|
Germany | €9.11 Billion |
|
Jack Henry & Associates Inc
NASDAQ:JKHY
|
USA | $915.75 Million |
|
Harel Insurance Investments & Financial Services Ltd
TA:HARL
|
Israel | ILA151.65 Billion |
Liability Composition Analysis (2010–2025)
This chart breaks down Globus Medical's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see GMED stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.56 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.15 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.13 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Globus Medical's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Globus Medical (2010–2025)
The table below shows the annual total liabilities of Globus Medical from 2010 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $729.51 Million | -32.10% |
| 2024-12-31 | $1.07 Billion | -1.26% |
| 2023-12-31 | $1.09 Billion | +373.61% |
| 2022-12-31 | $229.75 Million | +6.43% |
| 2021-12-31 | $215.88 Million | +24.65% |
| 2020-12-31 | $173.19 Million | +33.61% |
| 2019-12-31 | $129.62 Million | +12.57% |
| 2018-12-31 | $115.15 Million | +4.00% |
| 2017-12-31 | $110.72 Million | +15.87% |
| 2016-12-31 | $95.56 Million | -19.55% |
| 2015-12-31 | $118.78 Million | +0.58% |
| 2014-12-31 | $118.09 Million | +25.71% |
| 2013-12-31 | $93.94 Million | +54.94% |
| 2012-12-31 | $60.63 Million | +29.24% |
| 2011-12-31 | $46.91 Million | +22.24% |
| 2010-12-31 | $38.38 Million | -- |
About Globus Medical
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting… Read more